Nicholas Rogerson has been appointed as chairman of the board of directors at Telormedix, a Swiss biopharmaceutical company. Mr Rogerson has worked at Hoffmann-La Roche as global head of pharmaceutical business development and at Novartis as head of corporate mergers and acquisitions. He is also a former managing director of Bear Sterns, leading its European pharmaceutical merger and acquisition activities. Mr Rogerson holds a BSc from Sheffield University and an MSc from London University. He also has an MBA from Cranfield University School of Managment, UK.
Copyright 2011 Evernow Publishing